Market Cap 103.77B
Revenue (ttm) 359.05B
Net Income (ttm) 3.30B
EPS (ttm) N/A
PE Ratio 23.61
Forward PE 22.15
Profit Margin 0.92%
Debt to Equity Ratio -9.49
Volume 712,700
Avg Vol 706,396
Day's Range N/A - N/A
Shares Out 123.43M
Stochastic %K 71%
Beta 0.51
Analysts Strong Sell
Price Target $918.40

Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business soluti...

Industry: Medical Distribution
Sector: Healthcare
Phone: 972 446 4800
Address:
6555 State Highway 161, Irving, United States
VerticalitySchematics
VerticalitySchematics Nov. 14 at 10:30 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $EQNR $MCK $PAYX $PPG g
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 2:57 AM
$MCK: The current market context shows a last close at $846.24, with an RSI of 66.25 indicating that the stock is approaching overbought territory. The MA30 at $801.9 and MA50 at $770.31 suggest a bullish trend, as the price is above both moving averages. However, the RSI level indicates caution due to potential overextension. Directional bias is slightly bullish, supported by the price being near the 60D high of $867.63. The 60D low of $673.38 provides a solid support level. Suggested entry is at $840, slightly below the last close to confirm strength. Set a stop loss at $820 to manage risk. Target 1 is at $867.63 (60D high), and Target 2 is at $880, allowing for potential profit-taking as momentum continues. Monitor RSI for signs of reversal and adjust positions accordingly. https://privateprofiteers.com
0 · Reply
Mrstock2255
Mrstock2255 Nov. 13 at 11:02 PM
0 · Reply
MaverikIT
MaverikIT Nov. 13 at 9:42 PM
@IsabellaDC @TheLongVol @bearcharts $MCK $COR med distr combo
0 · Reply
MaverikIT
MaverikIT Nov. 13 at 6:11 PM
0 · Reply
amunka
amunka Nov. 13 at 12:58 PM
$MCK show me 350 today you beautiful bitch
0 · Reply
Magnatar
Magnatar Nov. 13 at 4:18 AM
$MCK need to do a split. my wife started working there 5 years ago and it was in the $200 tange. i am still waiting for a split 🙄
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:03 AM
$MCK is currently trading at $858.84, showing a strong upward trend with an RSI of 75.31, indicating overbought conditions. The price is above the 30-day moving average (MA30) of 796.54 and the 50-day moving average (MA50) of 764.26, suggesting bullish momentum. However, the high of $867.63 within the last 60 days is close to the current price, which may limit further upside potential. Directional bias is cautiously bullish, but the high RSI suggests a potential pullback. Suggested entry: $845 (to capture a slight retracement). Stop loss: $830 (to limit downside risk). Targets: $867 (60D High) and $880 (psychological resistance). Monitor for signs of reversal as price approaches the high. https://privateprofiteers.com
0 · Reply
ZZZZniiiiight
ZZZZniiiiight Nov. 12 at 12:09 PM
$MCK this is a money printer!!!! Probably one of the best stocks you could hold long term!!
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:39 AM
$MCK is currently trading at $858.84, showing a strong upward trend with an RSI of 75.31, indicating overbought conditions. The price is above the 30-day moving average (MA30) of 796.54 and the 50-day moving average (MA50) of 764.26, suggesting bullish momentum. However, the high of $867.63 within the last 60 days is close to the current price, which may limit further upside potential. Directional bias is cautiously bullish, but the high RSI suggests a potential pullback. Suggested entry: $845 (to capture a slight retracement). Stop loss: $830 (to limit downside risk). Targets: $867 (60D High) and $880 (psychological resistance). Monitor for signs of reversal as price approaches the high. https://privateprofiteers.com
0 · Reply
Latest News on MCK
McKesson Corporation (MCK) Q2 2026 Earnings Call Transcript

Nov 5, 2025, 7:21 PM EST - 8 days ago

McKesson Corporation (MCK) Q2 2026 Earnings Call Transcript


McKesson Corporation Declares Quarterly Dividend

Oct 30, 2025, 8:00 AM EDT - 14 days ago

McKesson Corporation Declares Quarterly Dividend


How to trade the health care break out

Oct 6, 2025, 2:24 PM EDT - 5 weeks ago

How to trade the health care break out

MRK UNH VEEV XBI XLV


See How McKesson Shares Rise with Money Flows

Oct 1, 2025, 7:28 AM EDT - 6 weeks ago

See How McKesson Shares Rise with Money Flows


McKesson Corporation (MCK) Analyst/Investor Day Transcript

Sep 23, 2025, 4:53 PM EDT - 7 weeks ago

McKesson Corporation (MCK) Analyst/Investor Day Transcript


McKesson Announces New Organizational Structure

Sep 18, 2025, 8:00 AM EDT - 2 months ago

McKesson Announces New Organizational Structure


McKesson Corporation (MCK) Q1 2026 Earnings Call Transcript

Aug 6, 2025, 6:43 PM EDT - 3 months ago

McKesson Corporation (MCK) Q1 2026 Earnings Call Transcript


McKesson Defied The Doubters (Including Me)--And Could Do It Again

Jul 26, 2025, 12:52 AM EDT - 3 months ago

McKesson Defied The Doubters (Including Me)--And Could Do It Again


Our Top 10 High Growth Dividend Stocks - July 2025

Jul 19, 2025, 8:00 AM EDT - 4 months ago

Our Top 10 High Growth Dividend Stocks - July 2025

APH AVGO BBVA BK CARR EME FIX


Our Top 10 High Growth Dividend Stocks - June 2025

Jun 21, 2025, 8:00 AM EDT - 5 months ago

Our Top 10 High Growth Dividend Stocks - June 2025

APH AVGO CF CTAS CTVA FIX HWM


McKesson to Host Investor Day on September 23, 2025

Jun 11, 2025, 8:00 AM EDT - 5 months ago

McKesson to Host Investor Day on September 23, 2025


McKesson Corporation Completes Acquisition of Core Ventures

Jun 3, 2025, 8:00 AM EDT - 5 months ago

McKesson Corporation Completes Acquisition of Core Ventures


McKesson: Sustained Rally Backed By Strong Financials

May 18, 2025, 3:40 AM EDT - 6 months ago

McKesson: Sustained Rally Backed By Strong Financials


Our Top 10 High-Growth Dividend Stocks -- May 2025

May 17, 2025, 8:30 AM EDT - 6 months ago

Our Top 10 High-Growth Dividend Stocks -- May 2025

AMH APH AVGO BCS BK BRO CI


McKesson To Spin-Off Its Medical-Surgical Solutions Business

May 15, 2025, 2:05 PM EDT - 6 months ago

McKesson To Spin-Off Its Medical-Surgical Solutions Business


McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript

May 8, 2025, 8:08 PM EDT - 6 months ago

McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript


McKesson to Spin Off Medical-Surgical Company

May 8, 2025, 5:40 PM EDT - 6 months ago

McKesson to Spin Off Medical-Surgical Company


McKesson Shares Rise Nearly 1% After Key Signal

Apr 24, 2025, 4:41 AM EDT - 7 months ago

McKesson Shares Rise Nearly 1% After Key Signal


Registration Opens for Annual McKesson ideaShare Conference

Apr 8, 2025, 9:00 AM EDT - 7 months ago

Registration Opens for Annual McKesson ideaShare Conference


Sit Out The Crash With These 5 Dividend Stocks

Apr 7, 2025, 11:55 AM EDT - 7 months ago

Sit Out The Crash With These 5 Dividend Stocks

MO NUE PEP PG


3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 7 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

COR CVS PM


McKesson Shares Up Over 2% After Key Signal

Apr 3, 2025, 6:59 AM EDT - 8 months ago

McKesson Shares Up Over 2% After Key Signal


VerticalitySchematics
VerticalitySchematics Nov. 14 at 10:30 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $EQNR $MCK $PAYX $PPG g
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 2:57 AM
$MCK: The current market context shows a last close at $846.24, with an RSI of 66.25 indicating that the stock is approaching overbought territory. The MA30 at $801.9 and MA50 at $770.31 suggest a bullish trend, as the price is above both moving averages. However, the RSI level indicates caution due to potential overextension. Directional bias is slightly bullish, supported by the price being near the 60D high of $867.63. The 60D low of $673.38 provides a solid support level. Suggested entry is at $840, slightly below the last close to confirm strength. Set a stop loss at $820 to manage risk. Target 1 is at $867.63 (60D high), and Target 2 is at $880, allowing for potential profit-taking as momentum continues. Monitor RSI for signs of reversal and adjust positions accordingly. https://privateprofiteers.com
0 · Reply
Mrstock2255
Mrstock2255 Nov. 13 at 11:02 PM
0 · Reply
MaverikIT
MaverikIT Nov. 13 at 9:42 PM
@IsabellaDC @TheLongVol @bearcharts $MCK $COR med distr combo
0 · Reply
MaverikIT
MaverikIT Nov. 13 at 6:11 PM
0 · Reply
amunka
amunka Nov. 13 at 12:58 PM
$MCK show me 350 today you beautiful bitch
0 · Reply
Magnatar
Magnatar Nov. 13 at 4:18 AM
$MCK need to do a split. my wife started working there 5 years ago and it was in the $200 tange. i am still waiting for a split 🙄
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:03 AM
$MCK is currently trading at $858.84, showing a strong upward trend with an RSI of 75.31, indicating overbought conditions. The price is above the 30-day moving average (MA30) of 796.54 and the 50-day moving average (MA50) of 764.26, suggesting bullish momentum. However, the high of $867.63 within the last 60 days is close to the current price, which may limit further upside potential. Directional bias is cautiously bullish, but the high RSI suggests a potential pullback. Suggested entry: $845 (to capture a slight retracement). Stop loss: $830 (to limit downside risk). Targets: $867 (60D High) and $880 (psychological resistance). Monitor for signs of reversal as price approaches the high. https://privateprofiteers.com
0 · Reply
ZZZZniiiiight
ZZZZniiiiight Nov. 12 at 12:09 PM
$MCK this is a money printer!!!! Probably one of the best stocks you could hold long term!!
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:39 AM
$MCK is currently trading at $858.84, showing a strong upward trend with an RSI of 75.31, indicating overbought conditions. The price is above the 30-day moving average (MA30) of 796.54 and the 50-day moving average (MA50) of 764.26, suggesting bullish momentum. However, the high of $867.63 within the last 60 days is close to the current price, which may limit further upside potential. Directional bias is cautiously bullish, but the high RSI suggests a potential pullback. Suggested entry: $845 (to capture a slight retracement). Stop loss: $830 (to limit downside risk). Targets: $867 (60D High) and $880 (psychological resistance). Monitor for signs of reversal as price approaches the high. https://privateprofiteers.com
0 · Reply
IN0V8
IN0V8 Nov. 11 at 5:18 PM
$MCK Deutsche Bank raises target price to $861 from $856
0 · Reply
ZZZZniiiiight
ZZZZniiiiight Nov. 11 at 1:40 PM
$OMI I work in medical sales and this company is a dying one that’s for sure. Better to invest it $CAH or Medline once they IPO. $BX owns a major stake in it. Also $MCK and $HSIC would be better investments.
1 · Reply
Okadarlan
Okadarlan Nov. 11 at 9:32 AM
$MCK more debt pls. Short here .
1 · Reply
amunka
amunka Nov. 10 at 7:49 PM
$MCK shouldve bought more of this
0 · Reply
IN0V8
IN0V8 Nov. 10 at 5:36 PM
$MCK Buy JP Morgan raises target price to $983 from $853 Wells Fargo raises target price to $914 from $816
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 2:25 PM
Wells Fargo has updated their rating for McKesson ( $MCK ) to Equal-Weight with a price target of 914.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Nov. 9 at 7:18 AM
my $MCK watchlist setup. patience until H% is very low like this.
0 · Reply
ZZZZniiiiight
ZZZZniiiiight Nov. 8 at 5:37 PM
$MCK $CAH once medline stock comes out I’ll be buying more. Will also add $BX and $BLK
0 · Reply
amunka
amunka Nov. 6 at 8:54 PM
$REGN and $MCK carrying my whole account right now
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 5:43 PM
UBS has updated their rating for McKesson ( $MCK ) to Buy with a price target of 980.
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 5:39 PM
Baird has adjusted their stance on McKesson ( $MCK ), setting the rating to Outperform with a target price of 873 → 927.
0 · Reply
IN0V8
IN0V8 Nov. 6 at 3:37 PM
$MCK Buy Baird raises target price to $927 from $873 TD Cowen raises target price to $1000 from $864
0 · Reply